Home > EMCDDA–Europol joint report on a new psychoactive substance: 4,4′-DMAR (4-methyl-5-(4-methylphenyl)-4,5-dihydrooxazol-2-amine.

European Monitoring Centre for Drugs and Drug Addiction. (2014) EMCDDA–Europol joint report on a new psychoactive substance: 4,4′-DMAR (4-methyl-5-(4-methylphenyl)-4,5-dihydrooxazol-2-amine. Luxembourg: Joint Reports, Publications Office of the European Union.

[img]
Preview
PDF (Full report) - Published Version
608kB

In February 2014, the EMCDDA and Europol examined the available information on a new psychoactive substance, 4-methyl-5-(4-methylphenyl)-4,5-dihydrooxazol-2-amine (commonly known by the abbreviation 4,4′-DMAR). The two organisations concluded that sufficient information had been accumulated to merit the production of a Joint Report on 4,4′-DMAR as stipulated by Article 5.1 of the Council Decision.
Table of contents
Introduction
Information collection process
Information required by Article 5.2 of the Council Decision
Information from the EMA as requested by Article 5.3 of the Council Decision
Conclusion
References
Annexes


Date:July 2014
Pages:20 p.
Publisher:Joint Reports, Publications Office of the European Union
Corporate Creators:European Monitoring Centre for Drugs and Drug Addiction
Place of Publication:Luxembourg
EndNote:View
Accession Number:HRB (Electronic Only)
Related URLs:
Subjects:B Drugs and alcohol substances > New (novel) psychoactive substances
L Social psychology and related concepts > Legal availability or accessibility
VA Geographic area > Europe

Repository Staff Only: item control page